Absci Corporation

Healthcare

NASDAQ:ABSI · NASDAQ Global Select

Market Cap $1.13B Beta 2.46 P/E (TTM) -9.4

$7.41 +1.04%

+$0.08 today

52W Low $2.24High $8.17

Vol 8.44M · Avg 5.10M

EPS (TTM) -$0.77Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+168.48%

Period High

$7.41

Period Low

$2.30

Latest

$7.41

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Erasca, Inc.

NASDAQ:ERAS

$4.33B

MoonLake Immunotherapeutics

NASDAQ:MLTX

$1.42B

MeiraGTx Holdings plc

NASDAQ:MGTX

$1.01B

Ventyx Biosciences, Inc.

VTYX

$1.00B

Corvus Pharmaceuticals, Inc.

NASDAQ:CRVS

$990.58M

Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

$803.40M

Prothena Corporation plc

NASDAQ:PRTA

$461.76M

REGENXBIO Inc.

NASDAQ:RGNX

$414.61M

Verastem, Inc.

NASDAQ:VSTM

$289.04M

Gossamer Bio, Inc.

GOSS

$38.42M

What is the latest ABSI filing?

The latest filing shown is 4/A dated Jun 15, 2026.

How many recent filings does ABSI have?

Intrinsic Alpha currently shows 20 recent filings for ABSI.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.